Vet360 Vet360 Vol 05 Issue 05 | Page 20

SMALL ANIMAL MEDICINE FELINE Table 2: Monitoring for pulmonary oedema whilst on fluid therapy Exercise intolerance Tachypnoea Referred breath sounds Inspiration is active, expiration is passive based on the elasticity of pulmonary tissue. Thus increased effort of expiration is an early sign of interstitial fluid accumulation. Referred breath sounds occur when the sound of normal air turbulence in the large bronchi is carried to the lung periphery due to interstitial fluid accumulation (sound travels better through a fluid than air). Respiratory distress Crackles on auscultation Moist soft cough Cyanosis Fluid is now also building up in the alveoli - causing crackles. IV fluids in AP patients. Each patient will be different. Providing balanced fluid support is important, with each patient being monitored closely and the fluid rates adapted appropriately. (Table 2) Oxygen Therapy Oxygen therapy is indicated if the patient is hypoxaemic or severely dyspnoeic. The assessment of a patients oxygenation can be done using arterial blood gas or pulse oximetry, with a PaO2 < 70mm Hg or an SPO2 <93% indicating hypoxaemia and the need for oxygen supplementation. If you do not have access to blood gas or pulse oximetry, use the clinical signs to guide you. In my opinion, if you are not sure if the patient needs oxygen, just supplement it, the only contraindication for giving oxygen is if the patient “is on fire”!! Nebulization Nebulization with 0.9% saline and coupage is used by most veterinarians with the thought that the this will allow the delivery of small drops of water into the respiratory tract to increase the hydration of the aqueous layer of the respiratory secretions, which will enhance the movement of theses secretions by the mucociliary apparatus. Despite the common use of nebulization and coupage, there is no evidence in veterinary medicine to support its use, in fact one veterinary study found no statistically significant links between nebulization treatments and survival to discharge and coupage has been associated with pulmonary atelectasis and gastroesophageal reflux in dogs. In human studies there is some evidence that suggests nebulizing with 3% hypertonic saline was more effective than normal saline. But even in the human studies the results are conflicting with many studies showing no clear benefit for the use of nebulization. With this in mind, and given the time and effort that goes into performing nebulization and coupage, the question is should we still be doing it? This should be left up to the clinician, to decide, but If nebulization is going to be used rather use hypertonic saline. Conclusion Aspiration pneumonia is common in canine veterinary patients and can have high morbidity and mortality rates if not treated. Apiration pneumonia can be vet360 Issue 05 | NOVEMBER 2018 | 20 prevented by identifying high risk patients and procedures and reducing risk factors where possible. High risk patients should be monitored closely to allow for early diagnosis and treatment when aspiration does occur. Survival rates of 77 – 82% have been reported in patients treated for AP so the prognosis is fair to good for patients treated correctly. References 1. Chih A, Rudloff E, Waldner C, Linklater AKJ. Incidence of hypo- chloremic metabolic alkalosis in dogs and cats with and without nasogastric tubes over a period of up to 36 hours in the intensive care unit. J Vet Emerg Crit Care 2018; 28(3): 244–251. 2. Cooper E. Clinical approach to aspiration pneumonia: evidence and opportunities. Proceedings 24th IVECCS congress, 2018, New Orleans, LA. 3. Dear JD. Bacterial Pneumonia in Dogs and Cats. Vet Clin Small Anim. 201; (44) 143–159. 4. De Legge MH. Managing gastric residual volumes in the critically ill patient: an update. Curr Opin Clin Nutr Metab Care 2011 14:193–196. 5. Goggs RA and Boag AK. Aspiration Pneumonitis and Pneumonia. In: Silverstein DC, Hopper K. Small Animal Critical Care Medicine. Saunders Elsevier: 2009. 6. Kogan DA, Johnson LR, Sturges BK, et al. Etiology and clinical out- come in dogs with aspiration pneumonia: 88 cases (2004-2006). J Am Vet Med Assoc 2008;233 (11):1748-1755. 7. Kogan DA, Johnson LR, Jandrey KE, Pollard RE. Clinical, clini- copathologic, and radiographic findings in dogs with aspiration pneumonia: 88 cases (2004–2006). J Am Vet Med Assoc. 2008;233(11):1742–1747. 8. Lappin MR, Blondeau J, Boothe D, et al. Antimicrobial use Guide- lines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases. J Vet Intern Med 2017;31(2):279-294. 9. Ovbey DH, Wilson DV, Bednarski RM, et al. Prevalence and risk factors for canine post-anesthetic aspiration pneumonia (1999– 2009): a multicenter study. Vet Anesth Analg 2014;41:127-136. 10. Savvas I, Raptopoulos D, Rallis T. A “light meal” three hours pre- operatively decreases the incidence of gastroesophageal reflux in dogs. J Am Anim Hosp Assoc 2016;52(6):357-63. 11. Schulze HM, Rahilly LJ. Aspiration Pneumonia in Dogs: Treat- ment, Monitoring, and Prognosis. Compend Contin Educ Vet. 2012;34(12):E1. 12. Schulze HM, Rahilly LJ. Aspiration pneumonia in dogs: patho- physiology, prevention, and diagnosis. Compend Contin Educ Vet. 2012;34(12):E5. 13. Sherman R, Karagiannis M. Aspiration Pneumonia in the Dog: A Review. Topics Compan An Med 2017;32:1-7. 14. Tart KM, Babski, DM, Lee JA. Potential risks, prognostic indicators, and diagnostic and treatment modalities affecting survival in dog with presumptive aspiration pneumonia: 125 cases (2005-2008). J Vet Emerg Crit Care 2010;20(3):319-329. 15. Viitanen SJ, Laurila HP, Lilja-Maula LI, Melamies MA, et al. Serum C-Reactive Protein as a diagnostic biomarker in dogs with bacterial respiratory diseases . J Vet Intern Med 2014;28:84–91 16. Wayne A, Davis M, Sinott VB, Bracker K. Outcomes in dogs with uncomplicated, presumptive bacterial pneumonia treated with short or long course antibiotics. Can Vet J 2017;58:610-613. 17. Wilson DV. Gastroesophageal reflux. Proceedings 24th IVECCS congress, 2018, New Orleans, LA.